We provide you with 20 years of free, institutional-grade data for PRLD stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PRLD. Explore the full financial landscape of PRLD stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about PRLD stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Prelude Therapeutics Incorporated(NASDAQ:PRLD) 
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of small molecule therapies optimized to target the key driver mechanisms in cancers. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid...
Website: http://www.preludetx.com
Founded: 2016
Full Time Employees: 55
CEO: Krishna Vaddi
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends